Table 1.
Patient | Treated | CD8+ at S (cells/mm2) | CD8+ at EOS (cells/mm2) | Fold change to CD8s | CD163+ at S (cells/mm2) | CD163+ at EOS (cells/mm2) | Ratio at S CD8/CD163 | Ratio at EOS CD8/CD163 | Fold change CD8:CD163 | FoxP3+ at S (cells/mm2) | FoxP3+ at EOS (cells/mm2) | Ratio at S CD8/FoxP3 | Ratio at EOS CD8/FoxP3 | Fold change CD8:FoxP3 | Total PD-L1 at S (cells/mm2) | Total PD-L1 at EOS (cells/mm2) | Fold change in PD-L1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | N | NA* | NA* | NA* | NA* | NA* | NA* | NA* | NA* | ||||||||
2 | Y | 635.31 | 410.79 | 0.65 | 2934.46 | 1542.39 | 0.22 | 0.27 | 1.23 | 74.40 | 104.21 | 8.54 | 3.94 | 0.46 | 5880.09 | 5818.34 | 0.99 |
3 | Y | 8.24 | 199.98 | 24.26 | 509.24 | 1102.63 | 0.02 | 0.18 | 11.20 | 8.24 | 28.73 | 1.00 | 6.96 | 6.96 | 1768.04 | 3645.96 | 2.06 |
4 | N | 91.74 | 66.00 | 0.72 | 1181.13 | 986.80 | 0.08 | 0.07 | 0.86 | 28.37 | 2.46 | 3.23 | 26.82 | 8.29 | 386.86 | 74.05 | 0.19 |
6 | Y | 97.57 | 458.59 | 4.7 | 1429.45 | 1018.55 | 0.07 | 0.45 | 6.60 | 62.04 | 142.56 | 1.57 | 3.22 | 2.05 | 2578.75 | 753.61 | 0.29 |
7 | Y | 50.77 | 78.90 | 1.55 | 2339.25 | 1236.81 | 0.02 | 0.06 | 2.94 | 56.91 | 44.63 | 0.89 | 1.77 | 1.98 | 5.01 | 139.03 | 27.73 |
8 | N | 159.44 | 277.12 | 1.74 | 1736.01 | 4983.88 | 0.09 | 0.06 | 0.61 | 158.59 | 77.30 | 1.01 | 3.59 | 3.57 | 6.80 | 295.57 | 43.48 |
10 | N | 78.94 | 24.96 | 0.32 | 504.38 | 3163.62 | 0.16 | 0.01 | 0.05 | 12.52 | 27.46 | 6.30 | 0.91 | 0.14 | 4258.22 | 6.39 | 0.001 |
11 | Y | 46.10 | 2444.31 | 53.02 | 2729.52 | 1792.39 | 0.02 | 1.36 | 80.74 | 2.46 | 406.59 | 18.74 | 6.01 | 0.32 | 281.36 | 2051.24 | 7.29 |
12 | N | 0.00 | 1626.32 | >1626.32 | 2310.30 | 4750.41 | NA | 0.34 | >0.34 | 2.52 | 351.85 | NA | 4.62 | >4.62 | 6869.22 | 668.08 | 0.10 |
Slides from patient 1 did not contain enough tissue to complete the analysis